Analytical Data
-
Gene name
CCRN4L
- Application
-
Alternative Names
CCRN4L；CCR4；CCRN4L；NOC；Nocturnin
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9UK39
-
Expression Region
1-431aa
-
AA Sequence
MFHSPRRLCS ALLQRDAPGL RRLPAPGLRR PLSPPAAVPR PASPRLLAAA SAASGAARSC SRTVCSMGTG TSRLYSALAK TLNSSAASQH PEYLVSPDPE HLEPIDPKEL LEECRAVLHT RPPRFQRDFV DLRTDCPSTH PPIRVMQWNI LAQALGEGKD NFVQCPVEAL KWEERKCLIL EEILAYQPDI LCLQEVDHYF DTFQPLLSRL GYQGTFFPKP WSPCLDVEHN NGPDGCALFF LQNRFKLVNS ANIRLTAMTL KTNQVAIAQT LECKESGRQF CIAVTHLKAR TGWERFRSAQ GCDLLQNLQN ITQGAKIPLI VCGDFNAEPT EEVYKHFASS SLNLNSAYKL LSADGQSEPP YTTWKIRTSG ECRHTLDYIW YSKHALNVRS ALDLLTEEQI GPNRLPSFNY PSDHLSLVCD FSFTEESDGL S
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CCRN4L (Cardiac and Cerebral Resident Neuronal 4-like) is a relatively newly identified protein that plays a crucial role in various cellular processes. Its study has gained attention because of its implications in cardiac and neuronal functions. The protein's unique structural features suggest that it may be involved in signaling pathways critical for maintaining cellular homeostasis and responding to stress. Recent research indicates that CCRN4L may participate in the regulation of apoptosis and cellular proliferation, which are vital in both normal development and disease contexts. Furthermore, preliminary findings have linked CCRN4L to cardiac pathologies and neurodegenerative diseases, highlighting its potential as a biomarker for these conditions. The exploration of CCRN4L's molecular mechanisms and its interactions with other cellular partners could pave the way for novel therapeutic strategies, particularly in targeting heart and brain-related diseases. As the understanding of this protein deepens, it may reveal new insights into the intricate networks that govern cell survival and death, offering hope for innovative interventions in related disorders. Thus, the ongoing study of CCRN4L is not only significant for basic science but also for translational medicine, providing a promising avenue for future research and drug development.
